发明名称 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
摘要 There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
申请公布号 US2004147559(A1) 申请公布日期 2004.07.29
申请号 US20030630258 申请日期 2003.07.30
申请人 SCHERING CORPORATION AND PHARMACOPEIA, INC. 发明人 TAVERAS ARTHUR G.;AKI CYNTHIA J.;BOND RICHARD W.;CHAO JIANPING;DWYER MICHAEL;FERREIRA JOHAN A.;CHAO JIANHUA;YU YOUNONG;BALDWIN JOHN J.;KAISER BERND;LI GE;MERRITT J. ROBERT;BIJU PURAKKATTLE J.;NELSON KINGSLEY H.;ROKOSZ LAURA L.;JAKWAY JAMES P.;LAI GAIFA;WU MINGLANG;HECKER EVAN A.;LUNDELL DANIEL;FINE JAY S.
分类号 C07C225/20;C07C237/30;C07C237/36;C07C237/44;C07C255/59;C07C311/39;C07D207/32;C07D207/335;C07D213/74;C07D217/24;C07D295/26;C07D307/38;C07D307/52;C07D307/68;C07D307/81;C07D307/82;C07D307/83;C07D317/46;C07D319/18;C07D333/20;C07D333/36;C07D405/12;C07D409/12;C07D409/14;C07D413/12;C07D413/14;(IPC1-7):C07D277/08;C07D263/02;C07D213/46;A61K31/443;A61K31/444 主分类号 C07C225/20
代理机构 代理人
主权项
地址